Literature DB >> 8115782

On the estimation of survival.

D E Henson1, L A Ries.   

Abstract

The advantages and disadvantages of the different methods for calculating survival according to the TNM (Topography, Lymph Node, and Metastasis) are described. Methods include the observed, relative, and conditional survival rates. For large cohorts, relative survival calculated by the life table method is most useful. Conditional survival, which requires long-term follow-up, is clinically the most informative. In addition, follow-up methods employed by tumor registries are considered.

Entities:  

Mesh:

Year:  1994        PMID: 8115782     DOI: 10.1002/ssu.2980100103

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  36 in total

1.  The conditional survival statistics for survivors with primary supratentorial astrocytic tumors.

Authors:  S L Hwang; Y H Yang; A S Lieu; M C Chuang; S J Chang; Y Y Chang; H J Lin; S L Howng
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

2.  Individualized estimation of conditional survival for patients with head and neck cancer.

Authors:  Samuel J Wang; Amanda R Wissel; Celine B Ord; Jayashree Kalpathy-Cramer; C David Fuller; John M Holland; Neil D Gross
Journal:  Otolaryngol Head Neck Surg       Date:  2011-07       Impact factor: 3.497

3.  Conditional survival in gastric cancer: a SEER database analysis.

Authors:  Samuel J Wang; Rachel Emery; Clifton D Fuller; Jong-Sung Kim; Dean F Sittig; Charles R Thomas
Journal:  Gastric Cancer       Date:  2007-09-26       Impact factor: 7.370

4.  Brain tumor survival: results from the National Cancer Data Base.

Authors:  T S Surawicz; F Davis; S Freels; E R Laws; H R Menck
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

5.  Conditional survival of all primary brain tumor patients by age, behavior, and histology.

Authors:  Kimberly R Porter; Bridget J McCarthy; Michael L Berbaum; Faith G Davis
Journal:  Neuroepidemiology       Date:  2011-06-16       Impact factor: 3.282

6.  Conditional survival in patients treated with vascular endothelial growth factor-targeted therapy for advanced renal cell carcinoma.

Authors:  Y Zhu; Y P Hong; H L Zhang; G H Shi; W J Xiao; Z H Wang; X D Yao; S L Zhang; B Dai; D W Ye
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-29       Impact factor: 4.553

7.  An interactive tool for individualized estimation of conditional survival in rectal cancer.

Authors:  Samuel J Wang; Amanda R Wissel; Join Y Luh; C David Fuller; Jayashree Kalpathy-Cramer; Charles R Thomas
Journal:  Ann Surg Oncol       Date:  2011-01-05       Impact factor: 5.344

8.  Prognosis and conditional disease-free survival among patients with ovarian cancer.

Authors:  Michelle L Kurta; Robert P Edwards; Kirsten B Moysich; Kathleen McDonough; Marnie Bertolet; Joel L Weissfeld; Janet M Catov; Francesmary Modugno; Clareann H Bunker; Roberta B Ness; Brenda Diergaarde
Journal:  J Clin Oncol       Date:  2014-11-17       Impact factor: 44.544

9.  Population-level trends in relative survival for cervical cancer.

Authors:  Jason D Wright; Ling Chen; Ana I Tergas; William M Burke; June Y Hou; Alfred I Neugut; Cande V Ananth; Dawn L Hershman
Journal:  Am J Obstet Gynecol       Date:  2015-07-23       Impact factor: 8.661

10.  Conditional Survival in Rectal Cancer: A SEER Database Analysis.

Authors:  Samuel J Wang; Clifton D Fuller; Rachel Emery; Charles R Thomas
Journal:  Gastrointest Cancer Res       Date:  2007-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.